The addition of lenvatinib and pembrolizumab to chemotherapy did not extend OS for certain patients with advanced ...

The phase 3 LEAP-015 trial evaluated the efficacy and safety of pembrolizumab with lenvatinib in patients with advanced/metastatic gastroesophageal cancer.

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the ...

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives,” published in the December ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

ImmunityBio has announced the launch of the Phase I/II QUILT 502 clinical trial of ANKTIVA (nogapendekin alfa inbakicept-pmln), plus the investigational AdHER2DC vaccine, as a potential therapy ...

近日，上海交通大学医学院附属仁济医院肿瘤介入科团队在国际权威期刊《Signal Transduction and Targeted Therapy》（STTT, ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...